AI Verdict
RLAY has stronger fundamentals based on our AI analysis.
RLAY vs RIVF Fundamental Comparison
| Metric | RLAY | RIVF |
|---|---|---|
| Revenue | $15.4M | $10.0M |
| Net Income | $-276.5M | $-966,090.0 |
| Net Margin | -1,800.6% | -9.7% |
| ROE | -48.8% | N/A |
| ROA | -44.5% | -5.3% |
| Current Ratio | 22.61x | 0.03x |
| Debt/Equity | 0.00x | N/A |
| EPS | $-1.61 | $-0.01 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RLAY vs RIVF: Frequently Asked Questions
Is RLAY or RIVF a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RLAY has stronger fundamentals. RLAY is rated SELL (78% confidence) while RIVF is rated STRONG SELL (88% confidence). This is not investment advice.
How does RLAY compare to RIVF fundamentally?
Relay Therapeutics, Inc. has ROE of -48.8% vs Rivulet Entertainment, Inc.'s N/A. Net margins are -1,800.6% vs -9.7% respectively.
Which stock pays higher dividends, RLAY or RIVF?
RLAY has a dividend yield of N/A or no dividend while RIVF has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RLAY or RIVF for long term?
For long-term investing, consider that RLAY has SELL rating with 78% confidence, while RIVF has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RLAY vs RIVF?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RLAY vs RIVF, the AI consensus favors RLAY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.